Difference between revisions of "Melanie Lee"

From Powerbase
Jump to: navigation, search
 
Line 1: Line 1:
Dr Lee studied as a postdoctoral scientist with the CRC and ICRF
+
Dr Lee studied as a postdoctoral scientist with the CRC and ICRF. She is currently Executive Vice-President Research and Development of [[UCB Pharma]], a Biopharmaceutical company. In 2003 she became a Chairman of Cancer Research Technology Limited (CRT). Also sits on the Parliamentary and Scientific Committee, is Chairman of the Applied Genomics LINK Scheme Programme Management Committee, is a member of the [[Biochemistry Society]] and the [[Genetics Society]]<ref>http://www.cancerresearchuk.org/aboutus/whoweare/howwearegoverned/trustees/</ref>
 
 
currently Executive Vice-President Research and Development of [[UCB Pharma]], a Biopharmaceutical company
 
 
 
in 2003 became a Chairman of Cancer Research Technology Limited (CRT)
 
 
 
sits on the Parliamentary and Scientific Committee, is Chairman of the Applied Genomics LINK Scheme Programme Management Committee, is a member of the [[Biochemistry Society]] and the [[Genetics Society]]<ref>http://www.cancerresearchuk.org/aboutus/whoweare/howwearegoverned/trustees/</ref>
 
  
 
==Notes==
 
==Notes==
 
<references/>
 
<references/>
 
[[Category:Patient Groups]]
 
[[Category:Patient Groups]]

Revision as of 17:00, 14 February 2008

Dr Lee studied as a postdoctoral scientist with the CRC and ICRF. She is currently Executive Vice-President Research and Development of UCB Pharma, a Biopharmaceutical company. In 2003 she became a Chairman of Cancer Research Technology Limited (CRT). Also sits on the Parliamentary and Scientific Committee, is Chairman of the Applied Genomics LINK Scheme Programme Management Committee, is a member of the Biochemistry Society and the Genetics Society[1]

Notes